ClinicalTrials.gg
RecruitingNCT07262840Updated Dec 4, 2025

Health Behavior Change in High-Risk Colorectal Cancer Individuals

An interventional study of Multi-component Health Promotion Lifestyle Intervention and Standard Care in Health Behavior, Colorectal Neoplasms and Primary Prevention/Methods, sponsored by China Medical University, China. Recruiting at 1 site in China. Open to participants aged 18 Months to 80 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-04.

Sponsored by China Medical University, China · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2026, 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2025; still recruiting 1 year later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Months to 80 Months
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Health Behavior with a site in China — 11 open to participants now, 13 under way, none of them phase 3. Health Behavior · China.

Planned enrollment
15th of 19
80 · median 136
Started
2025
with 1 other
No phase
18 of 28
6 open now
Primary completion
2026-02
later than 5 of 12 live
Registered
22nd of 28
by date
Lead sponsor
1 of 28
China Medical University, China

Among the 28 studies in Health Behavior with a site in China, this one is the 15th largest by planned enrollment of the 19 interventional ones that give a count, is one of 2 that started in 2025, is one of 18 with no phase, reaches primary completion later than 5 of the 12 other live ones, and was the 22nd registered.

Health Behavior

970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.

Browse Health Behavior studies →

Open to participants now

11 of the 28 studies in Health Behavior with a site in China are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 94 Health Behavior studies recruiting now, 39 (41%) set no upper age limit and 38 (40%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.

This study: 18 Months to 80 Months · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Health Behavior with a site in China, or all of them as a file.
02

Study summary

Background Colorectal cancer is a significant health concern. For individuals identified as being at high risk for developing this disease, adopting healthy lifestyle behaviors is a powerful way to lower that risk. However, starting and maintaining these new habits can be challenging. This study aims to test a comprehensive support program designed to help high-risk individuals make and sustain these positive health behavior changes.

Purpose The main goal of this research is to see if a specially designed 12-week health promotion program can effectively help high-risk individuals improve their lifestyle (e.g., diet, exercise, smoking/alcohol use), increase their knowledge about colorectal cancer, and strengthen their confidence and motivation to stay healthy.

Study Groups Participants in this study will be randomly assigned (like flipping a coin) to one of two groups:

  1. The Intervention Group: This group will take part in the 12-week health promotion program.
  2. The Control Group: This group will receive general health information or standard care but will not participate in the special program.

Procedures The program for the Intervention Group includes:

  • Educational Workshops: Five in-person group sessions to learn about cancer prevention, create personal health plans, and solve problems with others.
  • Online Support: Regular health articles and tips sent through a private WeChat group.
  • Daily Check-ins: Using the WeChat group for simple daily check-ins on exercise, fruit/vegetable intake, and smoking/alcohol use to build habit.
  • Peer Support: Being paired with a "health buddy" and interacting with other participants for motivation.

All participants will be asked to complete several questionnaires at the beginning of the study, during the program, and after it ends (at 3 months) to measure their knowledge, beliefs, and lifestyle habits.

Duration The active program lasts for 12 weeks.

Potential Benefits Participants in the Intervention Group may benefit from improved health habits, a better understanding of how to reduce their cancer risk, and increased social support. Participants in the control group will receive general health information. If they wish, they will receive the same health materials and behavioral change intervention as the intervention group after the intervention concludes.

03

Conditions studied

  • Health Behavior
  • Colorectal Neoplasms
  • Primary Prevention/Methods

Keywords

  • Health Promotion;Health Behavior;Lifestyle Intervention;High-Risk Population
04

Who can participate

Ages eligible
18 Months to 80 Months
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meets the criteria for being at high-risk for colorectal cancer as defined by the US National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colorectal Cancer Screening and the relevant Chinese expert consensus on colorectal cancer diagnosis and treatment.
  • Age ≥ 18 years.
  • Has normal verbal communication and comprehension abilities.
  • Provides and voluntarily agrees to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • Has a prior diagnosis of any (cancer).
  • Has a diagnosed severe psychiatric or psychological disorder.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Health Promotion Lifestyle Intervention Group

    Participants in this arm receive a 12-week, multi-component health promotion program based on the Health Promotion Model. The intervention includes: 1) Five in-person group workshops focusing on knowledge, motivation, planning, and maintenance; 2) Online support via a WeChat group for daily behavioral check-ins (e.g., exercise, diet) and peer support; 3) Educational articles and resources; 4) Techniques from Motivational Interviewing and Acceptance and Commitment Therapy to foster psychological adjustment and behavior change.

    Behavioral: Multi-component Health Promotion Lifestyle Intervention

  • Active comparator
    Standard Care

    Participants in this arm receive standard care, which may include general health information about colorectal cancer prevention. They do not participate in the structured workshops, online check-ins, or specialized support of the experimental intervention. They will complete all the same assessment questionnaires as the intervention group. They may be offered the intervention program after the study is complete (wait-list design).

    Other: Standard Care

Interventions

  • BehavioralMulti-component Health Promotion Lifestyle Intervention

    1. Intervention Name: Multi-Component Health Promotion Lifestyle Intervention 2. Description: This is a structured, theory-based intervention designed to facilitate health behavior change in individuals at high risk for colorectal cancer. It is distinguished by its foundation in the Health Promotion Model and the Integrative Model of Health Behavior Change, and its use of a blended online and offline delivery model over a 12-week period. The intervention is organized into five sequential modules: Cognitive Reconstruction: Provides essential knowledge about colorectal cancer (etiology, risk factors) and disease prevention strategies. Psychological Adjustment: Employs techniques from Motivational Interviewing to build intrinsic motivation and Acceptance and Commitment Therapy (ACT) to help participants manage distress and psychological barriers related to their cancer risk. Health Behavior Establishment: Guides participants in creating personalized health plans and builds self-effic

  • OtherStandard Care

    Participants randomised to the control arm will receive standard care, which may include general health advice or publicly available educational pamphlets on colorectal cancer prevention. They will not receive any component of the structured multi-component health promotion lifestyle intervention (i.e., no group workshops, no WeChat-based check-ins, no psychological techniques training, and no facilitated peer support). However, they will be asked to complete all the same assessment questionnaires at the same time points as the intervention group. Upon completion of the final follow-up assessment, participants in this arm will be offered the opportunity to receive the full intervention program (wait-list design).

06

What researchers measure

Primary outcomes

  1. Score change in the Health Promotion Lifestyle Scale for High-Risk Colorectal Cancer Population (HPLP-HRCP)

    This is the primary outcome measure, assessed using the revised Health Promotion Lifestyle Profile for High-Risk Colorectal Cancer Population (HPLP-HRCP). This scale measures the level of health-promoting lifestyle behaviors. A higher total score indicates a better health-promoting lifestyle.

    Time frame: Baseline (Week 0), Post-intervention (Week 12)

Secondary outcomes

  1. Score change in Colorectal Cancer Knowledge Questionnaire (CRC-KQ)

    Assessed using the 21-item Colorectal Cancer Knowledge Questionnaire. It consists of two dimensions: basic knowledge (15 items) and screening knowledge (6 items). Each correct answer scores 1 point. A higher total score indicates a higher level of colorectal cancer knowledge.

    Time frame: Baseline (Week 0), Post-intervention (Week 12).

  2. Score change in the Champion Health Belief Model Scale (CHBMS)

    Assessed using the Chinese version of the Champion Health Belief Model Scale. It contains 36 items across 6 dimensions: perceived susceptibility, perceived severity, perceived benefits, perceived barriers, health motivation, and self-efficacy. A higher score on a 5-point Likert scale indicates stronger health beliefs toward adopting recommended health behaviors.

    Time frame: Baseline (Week 0), Post-intervention (Week 12).

  3. Score change in the Multidimensional Health Locus of Control Scale (MHLC)

    Assessed using the Chinese version of the Multidimensional Health Locus of Control Scale. It has 18 items across 3 subscales (6 items each): Internal, Powerful Others, and Chance. Each subscale is scored from 6 to 36 on a 6-point Likert scale. A higher score on a subscale indicates a stronger tendency towards that specific locus of control.

    Time frame: Baseline (Week 0), Post-intervention (Week 12).

  4. Score change in the Kessler Psychological Distress Scale (K10)

    Assessed using the Chinese version of the 10-item Kessler Psychological Distress Scale. Total scores range from 10 to 50. Higher scores indicate higher levels of psychological distress. Scores are categorized as: 10-15 (Well), 16-21 (Mild), 22-29 (Moderate), and 30-50 (Severe) distress.

    Time frame: Baseline (Week 0), Post-intervention (Week 12).

  5. Score change in the Perceived Social Support Scale (PSSS)

    Assessed using the Chinese version of the Perceived Social Support Scale. It contains 12 items across 3 dimensions: family, friends, and significant others. Each item is rated on a 7-point Likert scale. A higher total score indicates a higher level of perceived social support.

    Time frame: Baseline (Week 0), Post-intervention (Week 12).

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — What IPD will be shared? Individual participant data that underlie the results reported in the primary and secondary publications after de-identification. This will include demographic data, baseline characteristics, and all outcome measure scores (e.g., HPLP-HRCP, CRC-KQ, CHBMS, MHLC, K10, PSSS). When will IPD be available? Beginning 9 months after the publication of the main trial results and ending 36 months thereafter. Who can access the IPD?? Researchers who provide a methodologically sound proposal for use in an independent ethical review-approved meta-analysis or replication study. How can IPD be accessed? Proposals should be directed to the corresponding author via email. To gain access, requestors will need to sign a data access agreement. Data will be shared via a secure file transfer platform. What other documents will be available? The study protocol, statistical analysis plan, and informed consent form will be made available on ClinicalTrials.gov alongside the results.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Feb 2026, 3 months after the start.

Of 569 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 3 months is below that.

Counting every sponsor, half of 587 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2025
First posted
Dec 4, 2025
StartActual
Nov 10, 2025
Primary completionEst.
Feb 10, 2026
CompletionEst.
Feb 10, 2026
Last update
Dec 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07262840
Lead sponsor
China Medical University, China
Responsible party
Wenna Qian (Doctoral Researcher, School of Nursing, China Medical University, China Medical University, China) — Principal investigator
First posted
Dec 4, 2025
Start date
Nov 10, 2025
Primary completion
Feb 10, 2026 (estimated)
Completion
Feb 10, 2026 (estimated)
Last update
Dec 4, 2025

Study contacts

Jialin Li
Contact
lijlpanda@163.com
15909836297

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion